Stromal vascular fraction technologies and clinical applications

References

• Zuk P. Adipose-derived stem cells in tissue regeneration: a review. ISRN Stem Cells. 2013;2013:35.
   Google Scholar
• Kuci S, Kuci Z, Latifi-Pupovci H, et al. Adult stem cells as an alternative source of multipotential (pluripotential) cells in regenerative medicine. Curr Stem Cell Res Ther. 2009 May;4(2):107–117.
   PubMed Web of Science ®Google Scholar
• Strioga M, Viswanathan S, Darinskas A, et al. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev. 2012 Sep 20;21(14):2724–2752.
   PubMed Web of Science ®Google Scholar
• Li CY, Wu XY, Tong JB, et al. Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy. Stem Cell Res Ther. 2015 Apr;13(6):55.
   Google Scholar
• Tsuji W, Rubin JP, Marra KG. Adipose-derived stem cells: implications in tissue regeneration. World J Stem Cells. 2014 Jul 26;6(3):312–321.
   PubMedGoogle Scholar
• Domenis R, Lazzaro L, Calabrese S, et al. Adipose tissue derived stem cells: in vitro and in vivo analysis of a standard and three commercially available cell-assisted lipotransfer techniques. Stem Cell Res Ther. 2015 Jan;5(6):2.
   Google Scholar
• van Dongen JA, Harmsen MC, van der Lei B, et al. Augmentation of dermal wound healing by adipose tissue-derived stromal cells (ASC). Bioengineering (Basel). 2018 Oct 26;5(4):E91.
   PubMedGoogle Scholar
• Bourin P, Bunnell BA, Casteilla L, et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy. 2013 Jun;15(6):641–648.
   PubMed Web of Science ®Google Scholar
• Später T, Frueh FS, Nickels RM, et al. Prevascularization of collagen-glycosaminoglycan scaffolds: stromal vascular fraction versus adipose tissue-derived microvascular fragments. J Biol Eng. 2018;12:24.
   PubMed Web of Science ®Google Scholar
• Nyberg E, Farris A, O’Sullivan A, et al. Comparison of SVF and passaged ASCs as point-of-care agents for bone regeneration. Tissue Eng Part A. 2019 Feb; 8. doi:10.1089/ten.TEA.2018.0341 [Epub ahead of print].
   Google Scholar
• Sheu JJ, Lee MS, Wallace CG, et al. Therapeutic effects of adipose derived fresh stromal vascular fraction-containing stem cells versus cultured adipose derived mesenchymal stem cells on rescuing heart function in rat after acute myocardial infarction. Am J Transl Res. 2019;11(1):67–86.
   PubMed Web of Science ®Google Scholar
• Conde-Green A, Kotamarti VS, Sherman LS, et al. Shift toward mechanical isolation of adipose-derived stromal vascular fraction: review of upcoming techniques. Plast Reconstr Surg Glob Open. 2016 Sep;4(9):e1017.
   PubMedGoogle Scholar
• Oberbauer E, Steffenhagen C, Wurzer C, et al. Enzymatic and non-enzymatic isolation systems for adipose tissue-derived cells: current state of the art. Cell Regen. 2015;4:7.
   PubMedGoogle Scholar
• van Dongen JA, Tuin AJ, Spiekman M, et al. Comparison of intraoperative procedures for isolation of clinical grade stromal vascular fraction for regenerative purposes: a systematic review. J Tissue Eng Reg Med. 2018 Jan;12(1):e261–e274.
   PubMed Web of Science ®Google Scholar
• Bora P, Majumdar AS. Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation. Stem Cell Res Ther. 2017 Jun 15;8(1):145.
   PubMed Web of Science ®Google Scholar
• van Dongen JA, Stevens HP, Harmsen MC, et al. Mechanical micronization of lipoaspirates: squeeze and emulsification techniques. Plast Reconstr Surg. 2017 Jun;139(6):1369e–1370e.
   PubMed Web of Science ®Google Scholar
• Aronowitz JA, Ellenhorn JD. Adipose stromal vascular fraction isolation: a head-to-head comparison of four commercial cell separation systems. Plast Reconstr Surg. 2013 Dec;132(6):932e–9e.
   PubMed Web of Science ®Google Scholar
• van Dongen JA, Stevens HP, Parvizi M, et al. The fractionation of adipose tissue procedure to obtain stromal vascular fractions for regenerative purposes. Wound Repair Regen. 2016 Nov;24(6):994–1003.
   PubMed Web of Science ®Google Scholar
• Zimmerlin L, Donnenberg VS, Rubin JP, et al. Mesenchymal markers on human adipose stem/progenitor cells. Cytometry A. 2013 Jan;83(1):134–140.
   PubMedGoogle Scholar
• Keramaris NC, Kaptanis S, Moss HL, et al. Endothelial progenitor cells (EPCs) and mesenchymal stem cells (MSCs) in bone healing. Curr Stem Cell Res Ther. 2012 Jul;7(4):293–301.
   PubMed Web of Science ®Google Scholar
• Lu H, Wang F, Mei H, et al. Human adipose mesenchymal stem cells show more efficient angiogenesis promotion on endothelial colony-forming cells than umbilical cord and endometrium. Stem Cells Int. 2018;2018:7537589.
   PubMedGoogle Scholar
• Freiman A, Shandalov Y, Rozenfeld D, et al. Adipose-derived endothelial and mesenchymal stem cells enhance vascular network formation on three-dimensional constructs in vitro. Stem Cell Res Ther. 2016 Jan;11(7):5.
   Google Scholar
• Chae DS, Han S, Son M, et al. Stromal vascular fraction shows robust wound healing through high chemotactic and epithelialization property. Cytotherapy. 2017 Apr;19(4):543–554.
   PubMed Web of Science ®Google Scholar
• Jin E, Chae DS, Son M, et al. Angiogenic characteristics of human stromal vascular fraction in ischemic hindlimb. Int J Cardiol. 2017 May 1;234:38–47.
   PubMed Web of Science ®Google Scholar
• Riordan NH, Ichim TE, Min WP, et al. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med. 2009 Apr;24(7):29.
   Web of Science ®Google Scholar
• Semon JA, Zhang X, Pandey AC, et al. Administration of murine stromal vascular fraction ameliorates chronic experimental autoimmune encephalomyelitis. Stem Cells Transl Med. 2013 Oct;2(10):789–796.
   PubMed Web of Science ®Google Scholar
• Bowles AC, Strong AL, Wise RM, et al. Adipose stromal vascular fraction-mediated improvements at late-stage disease in a murine model of multiple sclerosis. Stem Cells. 2017 Feb;35(2):532–544.
   PubMed Web of Science ®Google Scholar
• Caplan A, Badylak SF, Caplan AI, et al. Author accountability in biomedical research. Stem Cells Dev. 2018 Nov;20. doi: 10.1089/scd.2018.0214
   Google Scholar
• Salgado AJ, Reis RL, Sousa NJ, et al. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther. 2010 Jun;5(2):103–110.
   PubMed Web of Science ®Google Scholar
• Blaber SP, Webster RA, Hill CJ, et al. Analysis of in vitro secretion profiles from adipose-derived cell populations. J Transl Med. 2012 Aug 22;10:172.
   PubMed Web of Science ®Google Scholar
• de Witte SFH, Luk F, Sierra Parraga JM, et al. Immunomodulation by therapeutic mesenchymal stromal cells (MSC) is triggered through phagocytosis of MSC by monocytic cells. Stem Cells. 2018 Apr;36(4):602–615.
   PubMed Web of Science ®Google Scholar
• Cai W, Yu LD, Tang X, et al. The stromal vascular fraction improves maintenance of the fat graft volume: a systematic review. Ann Plast Surg. 2018 Sep;81(3):367–371.
   PubMed Web of Science ®Google Scholar
• Kosaric N, Kiwanuka H, Gurtner GC. Stem cell therapies for wound healing. Expert Opin Biol Ther. 2019 Mar;22:1–11.
   Google Scholar
• Holm JS, Toyserkani NM, Sorensen JA. Adipose-derived stem cells for treatment of chronic ulcers: current status. Stem Cell Res Ther. 2018 May 15;9(1):142.
   PubMedGoogle Scholar
• Li P, Guo X. A review: therapeutic potential of adipose-derived stem cells in cutaneous wound healing and regeneration. Stem Cell Res Ther. 2018 Nov 8;9(1):302.
   PubMedGoogle Scholar
• Usuelli FG, D’Ambrosi R, Maccario C, et al. Adipose-derived stem cells in orthopaedic pathologies. Br Med Bull. 2017 Dec 1;124(1):31–54.
   PubMed Web of Science ®Google Scholar
• Ha CW, Park YB, Kim SH, et al. Intra-articular mesenchymal stem cells in osteoarthritis of the knee: a systematic review of clinical outcomes and evidence of cartilage repair. Arthroscopy. 2019 Jan;35(1):277–288.e2.
   PubMed Web of Science ®Google Scholar
• Murdoch B, Zarzeczny A, Caulfield T. Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites’ marketing of stem cell therapies. BMJ Open. 2018 Feb 28;8(2):e019414.
   PubMed Web of Science ®Google Scholar
• Hass R, Kasper C, Bohm S, et al. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011 May;14(9):12.
   Google Scholar
• Bansal H, Comella K, Leon J, et al. Intra-articular injection in the knee of adipose derived stromal cells (stromal vascular fraction) and platelet rich plasma for osteoarthritis. J Trans Med. 2017 Jun 19;15.
   PubMed Web of Science ®Google Scholar
• Cattaneo G, De Caro A, Napoli F, et al. Micro-fragmented adipose tissue injection associated with arthroscopic procedures in patients with symptomatic knee osteoarthritis. BMC Musculoskelet Disord. 2018 May 30;19(1):176.
   PubMedGoogle Scholar
• Comella K, Silbert R, Parlo M. Effects of the intradiscal implantation of stromal vascular fraction plus platelet rich plasma in patients with degenerative disc disease. J Trans Med. 2017 Jan 13;15(1):12.
   PubMed Web of Science ®Google Scholar
• Fodor PB, Paulseth SG. Adipose derived stromal cell (ADSC) injections for pain management of osteoarthritis in the human knee joint. Aesthetic Surg J. 2016 Feb;36(2):229–236.
   PubMed Web of Science ®Google Scholar
• Gibbs N, Diamond R, Sekyere EO, et al. Management of knee osteoarthritis by combined stromal vascular fraction cell therapy, platelet-rich plasma, and musculoskeletal exercises: a case series. J Pain Res. 2015;8:799–806.
   PubMed Web of Science ®Google Scholar
• Hong Z, Chen J, Zhang S, et al. Intra-articular injection of autologous adipose-derived stromal vascular fractions for knee osteoarthritis: a double-blind randomized self-controlled trial. Int Orthop. 2019 May;43(5):1123–1134.
   PubMed Web of Science ®Google Scholar
• Hong-Thien Bui K, Duong T, Thanh Nguyen N, et al. Symptomatic knee osteoarthritis treatment using autologous adipose derived stem cells and platelet-rich plasma: a clinical study. Biomed Res Ther. 2014;1(1):2–8.
   Google Scholar
• Kim YS, Choi YJ, Suh DS, et al. Mesenchymal stem cell implantation in osteoarthritic knees: is fibrin glue effective as a scaffold? Am J Sports Med. 2015 Jan;43(1):176–185.
   PubMed Web of Science ®Google Scholar
• Kim YS, Choi YJ, Lee SW, et al. Assessment of clinical and MRI outcomes after mesenchymal stem cell implantation in patients with knee osteoarthritis: a prospective study. Osteoarthritis Cartilage. 2016 Feb;24(2):237–245.
   PubMed Web of Science ®Google Scholar
• Kim YS, Lee HJ, Choi YJ, et al. Does an injection of a stromal vascular fraction containing adipose-derived mesenchymal stem cells influence the outcomes of marrow stimulation in osteochondral lesions of the talus? A clinical and magnetic resonance imaging study. Am J Sports Med. 2014 Oct;42(10):2424–2434.
   PubMed Web of Science ®Google Scholar
• Kim YS, Choi YJ, Koh YG. Mesenchymal stem cell implantation in knee osteoarthritis: an assessment of the factors influencing clinical outcomes. Am J Sports Med. 2015 Sep;43(9):2293–2301.
   PubMed Web of Science ®Google Scholar
• Kim YS, Kwon OR, Choi YJ, et al. Comparative matched-pair analysis of the injection versus implantation of mesenchymal stem cells for knee osteoarthritis. Am J Sports Med. 2015 Nov;43(11):2738–2746.
   PubMed Web of Science ®Google Scholar
• Kim YS, Park EH, Kim YC, et al. Clinical outcomes of mesenchymal stem cell injection with arthroscopic treatment in older patients with osteochondral lesions of the talus. Am J Sports Med. 2013 May;41(5):1090–1099.
   PubMed Web of Science ®Google Scholar
• Kim YS, Koh YG. Comparative matched-pair analysis of open-wedge high tibial osteotomy with versus without an injection of adipose-derived mesenchymal stem cells for varus knee osteoarthritis: clinical and second-look arthroscopic results. Am J Sports Med. 2018 Sep;46(11):2669–2677.
   PubMed Web of Science ®Google Scholar
• Koh YG, Kwon OR, Kim YS, et al. Comparative outcomes of open-wedge high tibial osteotomy with platelet-rich plasma alone or in combination with mesenchymal stem cell treatment: a prospective study. Arthroscopy. 2014 Nov;30(11):1453–1460.
   PubMed Web of Science ®Google Scholar
• Koh YG, Jo SB, Kwon OR, et al. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthroscopy. 2013 Apr;29(4):748–755.
   PubMed Web of Science ®Google Scholar
• Koh YG, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee. 2012 Dec;19(6):902–907.
   PubMed Web of Science ®Google Scholar
• Koh YG, Choi YJ, Kwon OR, et al. Second-look arthroscopic evaluation of cartilage lesions after mesenchymal stem cell implantation in osteoarthritic knees. Am J Sports Med. 2014 Jul;42(7):1628–1637.
   PubMed Web of Science ®Google Scholar
• Koh YG, Choi YJ, Kwon SK, et al. Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2015 May;23(5):1308–1316.
   PubMed Web of Science ®Google Scholar
• Koh YG, Kwon OR, Kim YS, et al. Adipose-derived mesenchymal stem cells with microfracture versus microfracture alone: 2-year follow-up of a prospective randomized trial. Arthroscopy. 2016 Jan;32(1):97–109.
   PubMed Web of Science ®Google Scholar
• Hudetz D, Boric I, Rod E, et al. The effect of intra-articular injection of autologous microfragmented fat tissue on proteoglycan synthesis in patients with knee osteoarthritis. Genes (Basel). 2017 Oct 13;8(10).
   PubMed Web of Science ®Google Scholar
• Michalek J, Vrablikova A, Darinskas A, et al. Stromal vascular fraction cell therapy for osteoarthritis in elderly: multicenter case-control study. J Clin Orthop Trauma. 2019 January - February;10(1):76–80.
   PubMedGoogle Scholar
• Nguyen PD, Tran TDX, Nguyen HTN, et al. Comparative clinical observation of arthroscopic microfracture in the presence and absence of a stromal vascular fraction injection for osteoarthritis. Stem Cells Transl Med. 2017 January;6(1):187–195.
   PubMed Web of Science ®Google Scholar
• Panchal J, Malanga G, Sheinkop M. Safety and efficacy of percutaneous injection of lipogems micro-fractured adipose tissue for osteoarthritic knees. Am J Orthop. 2018 Nov;47:11.
   Google Scholar
• Panni AS, Vasso M, Braile A, et al. Preliminary results of autologous adipose-derived stem cells in early knee osteoarthritis: identification of a subpopulation with greater response. Int Orthop. 2019 Jan;43(1):7–13.
   PubMed Web of Science ®Google Scholar
• Pak J, Lee JH, Park KS, et al. Regeneration of cartilage in human knee osteoarthritis with autologous adipose tissue-derived stem cells and autologous extracellular matrix. Biores Open Access. 2016 Aug;5(1):192–200.
   PubMed Web of Science ®Google Scholar
• Pak J, Chang JJ, Lee JH, et al. Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints. BMC Musculoskelet Disord. 2013 Dec;1(14):337.
   Google Scholar
• Pak J, Lee JH, Lee SH. A novel biological approach to treat chondromalacia patellae. PloS One. 2013;8(5):e64569.
   PubMedGoogle Scholar
• Russo A, Screpis D, Di Donato SL, et al. Autologous micro-fragmented adipose tissue for the treatment of diffuse degenerative knee osteoarthritis: an update at 3 year follow-up. J Exp Orthop. 2018 Dec 01;5(1):52.
   PubMedGoogle Scholar
• Spasovski D, Spasovski V, Bascarevic Z, et al. Intra-articular injection of autologous adipose-derived mesenchymal stem cells in the treatment of knee osteoarthritis. J Gene Med. 2018 Jan;20(1). doi: 10.1002/jgm.3002
   PubMed Web of Science ®Google Scholar
• Yokota N, Yamakawa M, Shirata T, et al. Clinical results following intra-articular injection of adipose-derived stromal vascular fraction cells in patients with osteoarthritis of the knee. Regen Ther. 2017;6:108–112.
   PubMed Web of Science ®Google Scholar
• HJ P, EA S, Ten BCM, et al. Bone regeneration using the freshly isolated autologous stromal vascular fraction of adipose tissue in combination with calcium phosphate ceramics. Stem Cells Transl Med. 2016 Oct;5(10):1362–1374.
   PubMed Web of Science ®Google Scholar
• Saxer F, Scherberich A, Todorov A, et al. Implantation of stromal vascular fraction progenitors at bone fracture sites: from a rat model to a first-in-man study. Stem Cells. 2016 Dec;34(12):2956–2966.
   PubMed Web of Science ®Google Scholar
• Tate-Oliver K, Alexander R. Combination of autologous adipose-derived tissue stromal vascular fraction plus high density platelet-rich plasma or bone marrow concentrates in achilles tendon tears. J Prolotherapy. 2013;5:895–912.
   Google Scholar
• Usuelli FG, Grassi M, Maccario C, et al. Intratendinous adipose-derived stromal vascular fraction (SVF) injection provides a safe, efficacious treatment for Achilles tendinopathy: results of a randomized controlled clinical trial at a 6-month follow-up [Journal Article; Randomized Controlled Trial]. Knee Surg Sports Traumatol Arthrosc. 2018;26(7):2000‐2010.
   Web of Science ®Google Scholar
• Albano D, Messina C, Usuelli FG, et al. Magnetic resonance and ultrasound in achilles tendinopathy: predictive role and response assessment to platelet-rich plasma and adipose-derived stromal vascular fraction injection. Eur J Radiol. 2017;95:130–135.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Song DH, Park JW, et al. Effect of bone marrow aspirate concentrate-platelet-rich plasma on tendon-derived stem cells and rotator cuff tendon tear. Cell Transplant. 2017 May 9;26(5):867–878.
   PubMed Web of Science ®Google Scholar
• Carstens MH, Gomez A, Cortes R, et al. Non-reconstructable peripheral vascular disease of the lower extremity in ten patients treated with adipose-derived stromal vascular fraction cells. Stem Cell Res. 2017;18:14–21.
   PubMed Web of Science ®Google Scholar
• Cervelli D, Gasparini G, Grussu F, et al. Autologous fat transplantation for the temporalis muscle flap donor site: our experience with 45 cases. Head Neck. 2014 Sep;36(9):1296–1304.
   PubMed Web of Science ®Google Scholar
• Darinskas A, Paskevicius M, Apanavicius G, et al. Stromal vascular fraction cells for the treatment of critical limb ischemia: a pilot study. J Transl Med. 2017 Jun 19;15.
   PubMed Web of Science ®Google Scholar
• Del Papa N, Di Luca G, Sambataro D, et al. Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis. Cell Transplant. 2015;24(11):2297–2305.
   PubMed Web of Science ®Google Scholar
• Deng C, Wang L, Feng J, et al. Treatment of human chronic wounds with autologous extracellular matrix/stromal vascular fraction gel: a STROBE-compliant study. Medicine (Baltimore). 2018 Aug;97(32):e11667.
   PubMed Web of Science ®Google Scholar
• Granel B, Daumas A, Jouve E, et al. Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial. Ann Rheum Dis. 2015 Dec;74(12):2175–2182.
   PubMed Web of Science ®Google Scholar
• Daumas A, Guillaume-Jugnot P, Magalon J, et al. Long term efficacy of subcutaneous injection of the autologous adiposederived stromal vascular fraction (SVF) in the fingers of patients with systemic sclerosis [Conference Abstract]. Fund Clin Pharmacol. 2015 April;1:17–18.
   Web of Science ®Google Scholar
• Guillaume-Jugnot P, Daumas A, Magalon J, et al. Autologous adipose-derived stromal vascular fraction in patients with systemic sclerosis: 12-month follow-up. Rheumatology (Oxford). 2016;55(2):301‐306.
   PubMed Web of Science ®Google Scholar
• Han SK, Kim HR, Kim WK. The treatment of diabetic foot ulcers with uncultured, processed lipoaspirate cells: a pilot study. Wound Rep Regen. 2010 Jul-Aug;18(4):342–348.
   PubMed Web of Science ®Google Scholar
• Konstantinow A, Arnold A, Djabali K, et al. Therapy of ulcus cruris of venous and mixed venous arterial origin with autologous, adult, native progenitor cells from subcutaneous adipose tissue: a prospective clinical pilot study. J Eur Acad Dermatol Venereol. 2017 Dec;31(12):2104–2118.
   PubMed Web of Science ®Google Scholar
• Marino G, Moraci M, Armenia E, et al. Therapy with autologous adipose-derived regenerative cells for the care of chronic ulcer of lower limbs in patients with peripheral arterial disease. J Surg Res. 2013 Nov;185(1):36–44.
   PubMed Web of Science ®Google Scholar
• Moon KC, Chung HY, Han SK, et al. Possibility of injecting adipose-derived stromal vascular fraction cells to accelerate microcirculation in ischemic diabetic feet: a pilot study. Int J Stem Cells. 2019 Mar 30;12(1):107–113.
   PubMed Web of Science ®Google Scholar
• Raposio E, Bertozzi N, Bonomini S, et al. Adipose-derived stem cells added to platelet-rich plasma for chronic skin ulcer therapy. Wounds. 2016 Apr;28(4):126–131.
   PubMed Web of Science ®Google Scholar
• Zollino I, Campioni D, Sibilla MG, et al. A phase II randomized clinical trial for the treatment of recalcitrant chronic leg ulcers using centrifuged adipose tissue containing progenitor cells. Cytotherapy. 2019 Feb;21(2):200–211.
   PubMed Web of Science ®Google Scholar
• Andjelkov K, Sforza M, Barisic G, et al. A novel method for treatment of chronic anal fissure: adipose-derived regenerative cells - a pilot study. Colorectal Dis. 2017 Jun;19(6):570–575.
   PubMed Web of Science ®Google Scholar
• Choi JY, Kim TH, Yang JD, et al. Adipose-derived regenerative cell injection therapy for postprostatectomy incontinence: a phase i clinical study. Yonsei Med J. 2016 September;57(5):1152–1158.
   PubMed Web of Science ®Google Scholar
• Giori A, Tremolada C, Vailati R, et al. Recovery of function in anal incontinence after micro-fragmented fat graft (Lipogems®) injection: two years follow up of the first 5 cases. CellR4. 2015;3(2):1544.
   Google Scholar
• Gotoh M, Yamamoto T, Kato M, et al. Regenerative treatment of male stress urinary incontinence by periurethral injection of autologous adipose-derived regenerative cells: 1-year outcomes in 11 patients. Int J Urol. 2014 Mar;21(3):294–300.
   PubMed Web of Science ®Google Scholar
• Haahr MK, Harken JC, Toyserkani NM, et al. A 12-month follow-up after a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase i clinical trial. Urology. 2018;121:203.e6-203.e13.
   PubMed Web of Science ®Google Scholar
• Haahr MK, Jensen CH, Toyserkani NM, et al. Safety and potential effect of a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase i clinical trial. EBioMedicine. 2016 Mar 01;5:204–210.
   PubMed Web of Science ®Google Scholar
• Lander EB, Berman MH, See JR. Stromal vascular fraction combined with shock wave for the treatment of Peyronie’s disease. Plast Reconstr Surg Global Open. 2016 Mar;4(3):e631.
   Web of Science ®Google Scholar
• Mizushima T, Takahashi H, Takeyama H, et al. A clinical trial of autologous adipose-derived regenerative cell transplantation for a postoperative enterocutaneous fistula. Surg Today. 2016 Jul;46(7):835–842.
   PubMed Web of Science ®Google Scholar
• Comella K, Parcero J, Bansal H, et al. Effects of the intramyocardial implantation of stromal vascular fraction in patients with chronic ischemic cardiomyopathy. J Transl Med. 2016 Jun 2;14(1):158.
   PubMedGoogle Scholar
• Henry TD, Pepine CJ, Lambert CR, et al. The Athena trials: autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction. Catheter Cardiovasc Intervention. 2017 Feb 1;89(2):169–177.
   PubMed Web of Science ®Google Scholar
• Houtgraaf JH, Den Dekker WK, van Dalen BM, et al. First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2012 Jan 31;59(5):539–540.
   PubMed Web of Science ®Google Scholar
• Konstanty-Kalandyk J, Bartus K, Piatek J, et al. Midterm outcomes of transmyocardial laser revascularization with intramyocardial injection of adipose derived stromal cells for severe refractory angina. Postepy W Kardiologii Interwencyjnej. 2018;14(2):176–182.
   PubMed Web of Science ®Google Scholar
• Perin EC, Sanz-Ruiz R, Sanchez PL, et al. Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: the PRECISE trial. Am Heart J. 2014 Jul;168(1):88–95.e2.
   PubMed Web of Science ®Google Scholar
• Comella K, Blas JAP, Ichim T, et al. Autologous stromal vascular fraction in the intravenous treatment of end-stage chronic obstructive pulmonary disease: a phase i trial of safety and tolerability. J Clin Med Res. 2017 Aug;9(8):701–708.
   PubMedGoogle Scholar
• Tzouvelekis A, Paspaliaris V, Koliakos G, et al. A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis. J Transl Med. 2013 July 15;11(1):171.
   PubMed Web of Science ®Google Scholar
• Mytsyk M, Isu G, Cerino G, et al. Paracrine potential of adipose stromal vascular fraction cells to recover hypoxia-induced loss of cardiomyocyte function. Biotechnol Bioeng. 2019 Jan;116(1):132–142.
   PubMed Web of Science ®Google Scholar
• Nanjundappa A, Raza JA, Dieter RS, et al. Cell transplantation for treatment of left-ventricular dysfunction due to ischemic heart failure: from bench to bedside. Expert Rev Cardiovasc Ther. 2007 Jan;5(1):125–131.
   PubMedGoogle Scholar
• Lee FY, Chen YL, Sung PH, et al. Intracoronary transfusion of circulation-derived CD34+ cells improves left ventricular function in patients with end-stage diffuse coronary artery disease unsuitable for coronary intervention. Crit Care Med. 2015 Oct;43(10):2117–2132.
   PubMed Web of Science ®Google Scholar
• Kelm NQ, Beare JE, Yuan F, et al. Adipose-derived cells improve left ventricular diastolic function and increase microvascular perfusion in advanced age. PloS One. 2018;13(8):e0202934.
   PubMed Web of Science ®Google Scholar
• Bright R, Bright M, Bright P, et al. Migraine and tension-type headache treated with stromal vascular fraction: a case series. J Med Case Rep. 2014 Jun;30(8):237.
   Google Scholar
• Calcagni M, Zimmermann S, Scaglioni MF, et al. The novel treatment of SVF-enriched fat grafting for painful end-neuromas of superficial radial nerve. Microsurgery. 2018 Mar;38(3):264–269.
   PubMed Web of Science ®Google Scholar
• Mauskop A, Rothaus KO. Stem cells in the treatment of refractory chronic migraines. Case Rep Neurol. 2017;9(2):149–155.
   PubMed Web of Science ®Google Scholar
• Malik P, Gaba S, Ahuja C, et al. Role of fat graft alone versus enriched fat graft with stromal vascular filtrate in painful amputation stump. Indian J Orthop. 2019 May-Jun;53(3):452–458.
   PubMed Web of Science ®Google Scholar
• Sakai Y, Takamura M, Seki A, et al. Phase I clinical study of liver regenerative therapy for cirrhosis by intrahepatic arterial infusion of freshly isolated autologous adipose tissue-derived stromal/stem (regenerative) cell. Regen Ther. 2017 Mar 9;6:52–64.
   PubMed Web of Science ®Google Scholar
• Sautereau N, Daumas A, Truillet R, et al. Efficacy of autologous microfat graft on facial handicap in systemic sclerosis patients. Plast Reconstr Surg Global Open. 2016 Mar;4(3):e660.
   Web of Science ®Google Scholar
• Zimmermann S, Fakin RM, Giesen T, et al. Stromal vascular fraction-enriched fat grafting for the treatment of symptomatic end-neuromata. J Vis Exp. 2017 Nov;23(129). doi:10.3791/55962
   Google Scholar
• Toyserkani NM, Jorgensen MG, Tabatabaeifar S, et al. Concise review: a safety assessment of adipose-derived cell therapy in clinical trials: a systematic review of reported adverse events. Stem Cells Transl Med. 2017 Sep;6(9):1786–1794.
   PubMed Web of Science ®Google Scholar
• Comella K, Parlo M, Daly R, et al. Safety analysis of autologous stem cell therapy in a variety of degenerative diseases and injuries using the stromal vascular fraction. J Clin Med Res. 2017 Nov;9(11):935–942.
   PubMedGoogle Scholar
• Kuriyan AE, Albini TA, Townsend JH, et al. Vision loss after intravitreal injection of autologous “Stem Cells” for AMD. N Engl J Med. 2017 Mar 16;376(11):1047–1053.
   PubMed Web of Science ®Google Scholar
• Tan SS, Loh W. The utility of adipose-derived stem cells and stromal vascular fraction for oncologic soft tissue reconstruction: is it safe? A matter for debate. Surgeon. 2017 Aug;15(4):186–189.
   PubMed Web of Science ®Google Scholar
• Kilinc MO, Santidrian A, Minev I, et al. The ratio of ADSCs to HSC-progenitors in adipose tissue derived SVF may provide the key to predict the outcome of stem-cell therapy. Clin Transl Med. 2018 Feb 7;7(1):5.
   PubMedGoogle Scholar
• Yokota N, Hattori M, Ohtsuru T, et al. Comparative clinical outcomes after intra-articular injection with adipose-derived cultured stem cells or noncultured stromal vascular fraction for the treatment of knee osteoarthritis. Am J Sports Med. 2019 Sep;47(11):2577–2583.
   PubMed Web of Science ®Google Scholar
• Hoogduijn MJ, Lombardo E. Concise review: mesenchymal stromal cells Anno 2019: dawn of the therapeutic era? Stem Cells Transl Med. 2019 Jul 7.
   PubMed Web of Science ®Google Scholar